Murphy Pohlad Asset Management’s Zimmer Biomet ZBH Stock Holding History

Murphy Pohlad Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,700	Closed	-$386K	–	121
2022 Q3	$386K	Sell	3,700 -200	-5%	-$21.9K	0.18%	90
2022 Q2	$409K	Sell	3,900 -500	-11%	-$59.3K	0.18%	88
2022 Q1	$562K	Sell	4,400 -132	-3%	-$15.9K	0.23%	82
2021 Q4	$558K	Hold	4,532	–	–	0.22%	82
2021 Q3	$643K	Hold	4,532	–	–	0.26%	76
2021 Q2	$707K	Hold	4,532	–	–	0.29%	76
2021 Q1	$704K	Hold	4,532	–	–	0.31%	65
2020 Q4	$677K	Hold	4,532	–	–	0.34%	65
2020 Q3	$599K	Hold	4,532	–	–	0.32%	66
2020 Q2	$525K	Buy	+4,532	New	+$522K	0.29%	73

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Murphy Pohlad Asset Management's ZBH Position: Q4 2022 in Review

Murphy Pohlad Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 3,700 shares — an estimated $386K sold.

Murphy Pohlad Asset Management first reported a position in ZBH in Q2 2020 and held it in 10 quarters. The position peaked at $707K in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

Murphy Pohlad Asset Management reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
Murphy Pohlad Asset Management sold 3,700 Zimmer Biomet shares in Q4 2022, an estimated $386K.
Murphy Pohlad Asset Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 10 quarters.
Murphy Pohlad Asset Management's Zimmer Biomet position peaked at $707K in Q2 2021.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Murphy Pohlad Asset Management's 13F filing for Q4 2022, filed 6 Feb 2023.